Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04105335
Title A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT) (TIMEPOINT)
Acronym TIMEPOINT
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mina Alpha Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Facility Status City State Zip Country Details
Guys and St Thomas NHS Foundation Trust London SE1 9RT United Kingdom Details
Imperial College Healthcare NHS Trust London W12 0HS United Kingdom Details
Freeman Hospital, Newcastle Upn Tyne Hospitals NHS Foundation Trust Newcastle Upon Tyne NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field